To the CVM community here, I wish you all a very Happy New Year. I rarely post, as I am an amateur investor with very little of substance to add to the conversation, but I read every post here with great interest. I would like to extend my most sincere and heart-felt thanks to Fosco, Sushifishman, Lightrock, Cotton, Biobonic, Sab, Robot, G8, Master, (what happened to Learning Curve?), and others who momentarily escape me, for teaching me so much over the years. While the conversation here sometimes (unfortunately) takes a negative turn, nonetheless I have found immense value in the information and the perpectives that are shared here. Though I do not contribute often, I do think about the individuals whose posts I read, and I wonder about how each of you is doing. To everyone, thank you so much. I wish for each of you a very prosperous and safe New Year. May 2021 have many better things in store than 2020 did (shouldn't be hard to do...)
I have done as much DD as I know how to do over the past decade with Cel-Sci, and for personal (family) reasons, I want to believe in what Cel-Sci is doing. If anything, the company has true grit. I pray that they have discovered something that will benefit humanity, particularly those who suffer from the absolute horrors of cancer. We need more positivity in this world as badly as we need new treatments. As we head into 2021, I would like to wish everyone here the best of luck in all endeavors. If Multikine is a success, I will certainly profit, though I will not become rich. If they fail, I will lose money, but at least the lessons learned from the company's 30+ years of efforts in this direction will have made significant contributions to the knowledge that our best and brightest can use to create new, better treatments in the future, as they will surely be needed. I apologize for the long-winded post, and certainly don't expect any replies. This was meant merely to be a Thank You to so many who have taught me so much. Blessings and peace to all, and best of luck. Happy New Year.
